Mads Behrndt Email

Chief Financial Officer . Hemab Therapeutics

Copenhagen,

Location

m***@hemab.com

Primary Email

Current Roles

Employees:
51
Revenue:
$7.9M
About
Hemab ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.
Hemab Therapeutics Address
125 Cambridge Park Drive
Copenhagen, null
Hemab Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.